ARCHIVES

NCI’s Breast Cancer Screening Guidelines Released In Draft

This article is from The Cancer Letter archive.

Vol. 19 No. 37 | September 24, 1993

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Panel Unenthused About New Toxicity Testing Program

December 15, 1978